**Executive Summary**
On March 17, 2026, NIPER Raebareli and Roche Pharma India signed a Memorandum of Understanding (MoU) to advance pharmaceutical education and research in India. The partnership aims to bridge the gap between academic learning and industry practices by launching specialized certificate programmes and expert-led lecture series. This collaboration supports the national #BiopharmaShakti mission to transition India toward value-driven innovation and global leadership in the biopharmaceutical sector.
**Key Points / Main Content**
**Core Objectives and Partnership Goals**
* Foster academic collaboration to strengthen research and pharmaceutical education.
* Bridge the gap between theoretical learning and real-world industry practices.
* Equip students and faculty with insights into the evolving regulatory and pharmaceutical landscape.
**Specific Collaborative Initiatives**
* Development of a certificate programme in regulatory affairs for both students and industry professionals.
* Implementation of a guest lecture series featuring industry experts.
* Focus on emerging trends such as AI-driven pharmaceutical research, drug development, and healthcare innovation.
**Strategic National Alignment**
* Alignment with the Government’s #ViksitBharat vision and the #BiopharmaShakti mission.
* Emphasis on strengthening capabilities in regulatory sciences, biologics, and AI to achieve a global competitive advantage.
* Support for India’s transition from volume-led pharmaceutical growth to value-driven innovation.
**Impact Analysis**
**NIPER Raebareli Students and Faculty**
**Impact**
They will gain exposure to practical industry standards, emerging technologies like AI, and specialized knowledge in drug development and regulatory affairs.
**Action Required**
Participate in the upcoming guest lecture series and enroll in the certificate programme in regulatory affairs.
**Roche Pharma India**
**Impact**
The company will play a direct role in developing a future-ready workforce and fostering growth within India’s life sciences ecosystem.
**Action Required**
Provide industry experts for lectures and collaborate on the curriculum for the regulatory affairs certification.
**Pharmaceutical Industry Professionals**
**Impact**
Professionals in the sector gain access to specialized certification to enhance their understanding of the evolving regulatory landscape.
**Action Required**
Register for the certificate programme in regulatory affairs offered through this collaboration.
**Department of Pharmaceuticals / Government of India**
**Impact**
The collaboration fulfills the strategic need for academia-industry partnerships to consolidate India's global position in the biopharmaceutical sector.
**Action Required**
Continue oversight and support of such MoUs to meet the objectives of the #BiopharmaShakti mission.
Key Entities Referenced
NIPER Raebareli: National academic institute that signed an MoU to advance pharmaceutical education, research, and industry-ready training.
Roche Pharma India: Industry partner collaborating with NIPER on certificate programs, AI-driven research, and drug development initiatives.
BiopharmaShakti mission: A government initiative supporting India’s transition toward value-driven innovation and global leadership in the biopharmaceutical sector.
Department of Pharmaceuticals: The primary government body under the Ministry of Chemicals and Fertilizers overseeing the strategic partnership and regulatory landscape.
Manoj Joshi: Secretary of the Department of Pharmaceuticals who emphasized the need for strengthening capabilities in regulatory sciences and AI.
Ministry of Chemicals and Fertilizers :
Department of Pharmaceuticals
NIPER Raebareli Signs MoU with Roche Pharma
India to Strengthen Pharmaceutical Education
and Research
Posted On: 17 MAR 2026 7:25PM by PIB Delhi
National Institute of Pharmaceutical Education and Research Raebareli (NIPER Raebareli) signed a
Memorandum of Understanding (MoU) with Roche Pharma India to foster academic collaboration and
advance pharmaceutical education and research in India. The MoU was signed in the presence of Shri
Manoj Joshi, Secretary, Department of Pharmaceuticals under the Ministry of Chemicals and Fertilizers, at
Shastri Bhawan, New Delhi.
This strategic partnership aims to bridge the gap between academic learning and real-world industry
practices by equipping students and faculty with valuable insights into the evolving pharmaceutical and
regulatory landscape. Under the MoU, Roche and NIPER Raebareli will collaborate on initiatives such as
a certificate programme in regulatory affairs for students and industry professionals, guest lecture
series by industry experts on emerging trends including AI-driven pharmaceutical research, drug
development and healthcare innovation to strengthen practical industry understanding.
Shri Manoj Joshi emphasized that India needs to strengthen its capabilities in regulatory sciences,
biologics and AI in pharmaceuticals to achieve a sustained global competitive advantage and consolidate
its global position. He said academia-industry collaborations are critical to fulfilling these aspirations.
The collaboration aligns with the Government’s #ViksitBharat vision and the #BiopharmaShakti
mission, supporting India’s transition from volume-led pharmaceutical growth to value-driven innovation
and reinforcing the country’s global leadership in the biopharmaceutical sector.The initiative marks an important step toward developing a future-ready workforce and fostering
sustainable growth in India’s life sciences ecosystem.
***
PC/PM
(Release ID: 2241421) Visitor Counter : 159
Read this release in: Urdu , ही